1

TDI &Prevalence

First results of pilotprojectA.W.Ouwehand

W.Kuijpers

Lisbon: TDI meeting september 2006

2

TDI & Prevalence

Flash back at the project The project The First Data First Analysis Questions /First Answers Comments experts

Lisbon: TDI meeting september 2006

3

TDI Measures

New treatments. Repeated treatments after an

administrative break.

4

Definitions

All Treatments: All clients started in reference period.(EMCDDA)

Total Treatments: All clients in treatment in reference period (Pilot)

5

TDI does Not

Register continuous treatment relations.

Give a total view of treatment demand.

Give a clear view on trends in addiction and treatment demand.

Compare to national reports.

6

Proposal in Scientific Board

….. memo to extend the TDI to total prevalence

“In its current form, however, the TDI does not give insight into the total treatment

demand. Especially chronic clients that have been registered for longer periods are not reported by TDI-figures. Addiction being a

chronic disease, chronic clients consequently form a substantial part of the total

treatment demand. To give an impression about a country's total treatment demand and

the number of drug addicts that are being reached by treatment, it is therefore proposed to extend the TDI to all drug treatment cases

for a given reporting year. Comparing incidence cases to existing cases will also give further

insight into the division between new and old drug problems in Member States of the

European Union.”

7

Questions to start

Would it be possible to deliver the total treatment demand besides the 2005 TDI data?

Could it eventually be done at a later date (year)?

How can we advice the EMCDDA (Management Board/Scientific Board)?

Will it be possible for all/some countries? In what way does this effect the figures of

the EMCDDA and the presentation of TDI data?

8

Indicator of prevalence 2 All Clients in Treatment in 2005

K10

K11

K9

K8

K7

K6

K5

K4

K3

K2

K1

2005 2006

9

Pilot

Participating countries (data delivered) Au,Bg,Cz,F,Lv,Nl Participants Pl,MT,GR,HU (but no data

delivered yet) Data collection IVZ Netherlands

(W.Kuijpers) Based on 2004 and/or 2005 data Data structure: First ,All, Total treatment Presentation on “EMCDDA”level

10

The First Data

2004 2005 2005 2004 2005Netherlands Czech R. Austria Latvia Bulgaria EMCDDA

1. first treatment 4785 4372 61 401 388 100072. previous treatment 5102 3669 65 1038 9874missings 10 17 27All treatments 9887 8041 211 401 1440 199803. total 31519 8534 505 3766 2022 46346

Ratio All vs Total 16 43 13 11 51 22

Not for publication

11

The First DataSubstance Netherlands Czech R. Austria Latvia Bulgaria EMCDDA

All Total All Total All Total All Total All Total All Total1. Opiates (total) 2907 13928 1913 2058 69 206 134 2236 1363 1941 6386 20369 11 heroin 2484 12387 1567 1683 61 177 108 1622 1357 1935 5577 17804 12 methadone 331 1201 21 20 6 16 0 0 1 1 359 1238 13 other opiates 92 340 325 355 2 13 26 614 5 5 450 13272. Cocaine (total) 3623 9998 14 15 23 40 2 15 6 6 3668 10074 21 cocaine 3448 9596 12 13 22 39 2 15 6 6 3490 9669 22 crack 175 402 2 2 1 1 0 0 0 0 178 4053. Stimulants (total) 543 1317 4640 4891 18 30 110 539 13 13 5324 6790 31 amphetamines 401 954 4608 4856 8 15 95 359 11 11 5123 6195 32 MDMA and other derivates 110 291 21 23 10 15 7 14 2 2 150 345 33 other stimulants 32 59 11 9 0 8 106 0 0 51 1744. Hypnotics and Sedatives (total) 194 488 79 90 21 44 35 282 8 8 337 912 41 barbiturates 7 15 7 7 1 0 4 41 0 0 19 63 42 benzodiazepines 157 410 34 41 20 44 10 81 6 6 227 582 43 others 30 63 38 42 0 0 21 160 2 2 91 2675. Hallucinogens (total) 77 158 16 17 3 5 2 51 0 0 98 231 51 LSD 6 13 9 10 3 5 0 2 0 0 18 30 52 others 71 145 7 7 0 0 2 49 0 0 80 2016. Volatile Inhalants 5 0 170 182 0 1 19 204 1 1 195 3887. Cannabis (total) 2459 5456 1166 1239 66 152 68 352 46 46 3805 72459. Other Substances (total) 79 164 25 24 5 6 29 79 1 1 139 27499. Not known/Missing 0 10 18 18 6 21 2 8 2 6 28 63totaal 9887 31519 8041 8534 211 505 401 3766 1440 2022 19980 46346

Not for publication

12

Primary problem condensed

Substance Netherlands Czech R. Austria Latvia Bulgaria EMCDDAAll Total All Total All Total All Total All Total All Total

1. Opiates (total) 2907 13928 1913 2058 69 206 134 2236 1363 1941 6386 203692. Cocaine (total) 3623 9998 14 15 23 40 2 15 6 6 3668 100743. Stimulants (total) 543 1317 4640 4891 18 30 110 539 13 13 5324 67904. Hypnotics and Sedatives (total) 194 488 79 90 21 44 35 282 8 8 337 9125. Hallucinogens (total) 77 158 16 17 3 5 2 51 0 0 98 2316. Volatile Inhalants 5 0 170 182 0 1 19 204 1 1 195 3887. Cannabis (total) 2459 5456 1166 1239 66 152 68 352 46 46 3805 72459. Other Substances (total) 79 164 25 24 5 6 29 79 1 1 139 27499. Not known/Missing 0 10 18 18 6 21 2 8 2 6 28 63totaal 9887 31519 8041 8534 211 505 401 3766 1440 2022 19980 46346

Not for publication

13

Primary problem condensed

Substance EMCDDA EMCDDAAll Total % to emcdda

1. Opiates (total) 6386 20369 31

2. Cocaine (total) 3668 10074 36

3. Stimulants (total) 5324 6790 78

4. Hypnotics and Sedatives (total)337 912 37

5. Hallucinogens (total) 98 231 42

6. Volatile Inhalants 195 388 50

7. Cannabis (total) 3805 7245 53

9. Other Substances (total)139 274 51

99. Not known/Missing 28 63 44

totaal 19980 46346 43

Not for publication

14

Primary problem condensedin percentages

Substance EMCDDAAll Total

1. Opiates (total) 32 442. Cocaine (total) 18 223. Stimulants (total) 27 154. Hypnotics and Sedatives (total) 2 25. Hallucinogens (total) 0 06. Volatile Inhalants 1 17. Cannabis (total) 19 169. Other Substances (total) 1 199. Not known/Missing 0 0

Not for publication

15

Age distribution

Not for publication

Age categories Netherlands Czech R. Austria BulgariaAll Pilot All Pilot All Pilot All Pilot

< 24 years 25 15 57 57 62 53 59 5125-39 year 51 44 39 39 31 36 40 45> 40 year 24 36 4 4 7 11 5 4

16

Age distribution

Not for publication

Age categories EMCDDA PilotAll Total % all from Total

< 24 years 41 27 6325-39 year 45 46 41> 40 year 14 26 22

17

Questions/First Answers

Would it be possible to deliver the total treatment demand besides the 2005 TDI data?

Several countries are able to deliver these data Could it eventually be done at a later date (year)? Yes How can we advice the EMCDDA (Management

Board/Scientific Board)? To continue and widen up the experiment on voluntary

base Will it be possible for all/some countries? Has to be further discussed/investigated In what way does this effect the figures of the EMCDDA

and the presentation of TDI data? Most likely significantly